Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
September 04 2020 - 9:02AM
Edgar (US Regulatory)
Filed
Pursuant to Rule 424(b)(5)
Registration No. 333-237610
PROSPECTUS
SUPPLEMENT
(To
Prospectus Dated April 8, 2020)
$100,000,000
Common
Stock
This
prospectus supplement amends and supplements the information in the prospectus, dated April 8, 2020, filed as a part of our registration
statement on Form S-3 (File No. 333-237610), as previously supplemented by our prospectus supplement
dated April 8, 2020, or the Prior Prospectus. This prospectus supplement should be read in conjunction with the Prior Prospectus,
and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained
in the Prior Prospectus. This prospectus supplement is not complete without, and may only be delivered or utilized in connection
with, the Prior Prospectus, and any future amendments or supplements thereto.
Under the
Prior Prospectus, we initially registered up to $50,000,000 of our Common Stock, $0.001 par value per share, for offer and sale
pursuant to a Sales Agreement, dated April 8, 2020, or the Sales Agreement, between us and A.G.P./Alliance Global Partners, or
AGP. From April 8, 2020 through the date of this prospectus supplement, we sold an aggregate of 52,986,301 shares of our
Common Stock for an aggregate purchase price of $35,275,680 under the Prior Prospectus. As of the date of this prospectus
supplement, we are increasing the aggregate amount of Common Stock that we are offering pursuant to the Sales Agreement, such
that we are offering up to an aggregate of $100,000,000 of our Common Stock for sale under the Sales Agreement, including the
shares of Common Stock previously sold, or $64,724,320 from and after the date hereof.
Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary
is a criminal offense.
A.G.P.
The date
of this prospectus supplement is September 4, 2020.
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Sep 2023 to Sep 2024